Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1964
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 2
1966 3
1967 17
1968 14
1969 18
1970 24
1971 30
1972 38
1973 28
1974 33
1975 23
1976 19
1977 26
1978 24
1979 27
1980 23
1981 28
1982 19
1983 34
1984 41
1985 53
1986 56
1987 72
1988 118
1989 119
1990 144
1991 174
1992 230
1993 249
1994 223
1995 232
1996 243
1997 363
1998 358
1999 453
2000 483
2001 438
2002 564
2003 638
2004 686
2005 595
2006 761
2007 835
2008 835
2009 830
2010 897
2011 980
2012 1059
2013 1084
2014 1081
2015 1225
2016 1329
2017 1480
2018 1348
2019 1413
2020 1544
2021 1677
2022 1550
2023 1487
2024 1689
2025 60

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

27,113 results

Results by year

Filters applied: . Clear all
Page 1
Challenges in the diagnosis of Parkinson's disease.
Tolosa E, Garrido A, Scholz SW, Poewe W. Tolosa E, et al. Lancet Neurol. 2021 May;20(5):385-397. doi: 10.1016/S1474-4422(21)00030-2. Lancet Neurol. 2021. PMID: 33894193 Free PMC article. Review.
Parkinson's disease is the second most common neurodegenerative disease and its prevalence has been projected to double over the next 30 years. An accurate diagnosis of Parkinson's disease remains challenging and the characterisation of the earl
Parkinson's disease is the second most common neurodegenerative disease and its prevalence has been projected to double
[Parkinson's Disease: Clinical Review and Update].
Cabreira V, Massano J. Cabreira V, et al. Acta Med Port. 2019 Oct 1;32(10):661-670. doi: 10.20344/amp.11978. Acta Med Port. 2019. PMID: 31625879 Free article. Review. Portuguese.
Parkinson's disease is the second most common neurodegenerative disorder, and a significant increase in its prevalence in the past three decades has been documented. ...There is no absolute method to diagnose Parkinson's disease in vivo, except for gen
Parkinson's disease is the second most common neurodegenerative disorder, and a significant increase in its prevalence in the
Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology.
Simon DK, Tanner CM, Brundin P. Simon DK, et al. Clin Geriatr Med. 2020 Feb;36(1):1-12. doi: 10.1016/j.cger.2019.08.002. Epub 2019 Aug 24. Clin Geriatr Med. 2020. PMID: 31733690 Free PMC article. Review.
Parkinson disease is a complex, age-related, neurodegenerative disease associated with dopamine deficiency and both motor and nonmotor deficits. ...Ultimately, treatment of Parkinson disease may focus on targeted therapies for pathophysiological
Parkinson disease is a complex, age-related, neurodegenerative disease associated with dopamine deficiency and both mot
Parkinson's disease: a review.
Beitz JM. Beitz JM. Front Biosci (Schol Ed). 2014 Jan 1;6(1):65-74. doi: 10.2741/s415. Front Biosci (Schol Ed). 2014. PMID: 24389262 Free article. Review.
Parkinson's Disease is the second most common progressive neurodegenerative disorder affecting older American adults and is predicted to increase in prevalence as the United States population ages. Resulting from a pathophysiologic loss or degeneration of dopaminerg
Parkinson's Disease is the second most common progressive neurodegenerative disorder affecting older American adults and is pr
Parkinson's disease: etiopathogenesis and treatment.
Jankovic J, Tan EK. Jankovic J, et al. J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):795-808. doi: 10.1136/jnnp-2019-322338. Epub 2020 Jun 23. J Neurol Neurosurg Psychiatry. 2020. PMID: 32576618 Review.
The concept of 'idiopathic' Parkinson's disease (PD) as a single entity has been challenged with the identification of several clinical subtypes, pathogenic genes and putative causative environmental agents. ...The application of glucagon-like peptide one receptor a …
The concept of 'idiopathic' Parkinson's disease (PD) as a single entity has been challenged with the identification of several …
Parkinson's Disease in Women and Men: What's the Difference?
Cerri S, Mus L, Blandini F. Cerri S, et al. J Parkinsons Dis. 2019;9(3):501-515. doi: 10.3233/JPD-191683. J Parkinsons Dis. 2019. PMID: 31282427 Free PMC article. Review.
Increasing evidence points to biological sex as an important factor in the development and phenotypical expression of Parkinson's disease (PD). Risk of developing PD is twice as high in men than women, but women have a higher mortality rate and faster progression of …
Increasing evidence points to biological sex as an important factor in the development and phenotypical expression of Parkinson's …
The epidemiology of Parkinson's disease: risk factors and prevention.
Ascherio A, Schwarzschild MA. Ascherio A, et al. Lancet Neurol. 2016 Nov;15(12):1257-1272. doi: 10.1016/S1474-4422(16)30230-7. Epub 2016 Oct 11. Lancet Neurol. 2016. PMID: 27751556 Review.
Since 2006, several longitudinal studies have assessed environmental or behavioural factors that seem to modify the risk of developing Parkinson's disease. Increased risk of Parkinson's disease has been associated with exposure to pesticides, consumpti …
Since 2006, several longitudinal studies have assessed environmental or behavioural factors that seem to modify the risk of developing Pa
Parkinson's Disease.
Reich SG, Savitt JM. Reich SG, et al. Med Clin North Am. 2019 Mar;103(2):337-350. doi: 10.1016/j.mcna.2018.10.014. Epub 2018 Dec 3. Med Clin North Am. 2019. PMID: 30704685 Review.
The diagnosis of Parkinson disease (PD) is based on the presence of bradykinesia and either resting tremor or rigidity and there should be no features from the history or examination to suggest an alternative cause of parkinsonism. ...
The diagnosis of Parkinson disease (PD) is based on the presence of bradykinesia and either resting tremor or rigidity and the …
Pain in Parkinson's Disease: Pathophysiology, Classification and Treatment.
Cattaneo C, Jost WH. Cattaneo C, et al. J Integr Neurosci. 2023 Sep 8;22(5):132. doi: 10.31083/j.jin2205132. J Integr Neurosci. 2023. PMID: 37735139 Free article. Review.
As a result, people are living longer than during the past century, but this has also caused an increase of the prevalence of many neurological disorders. Parkinson's disease (PD) is the fastest growing neurological condition, with a doubling of cases reported betwe …
As a result, people are living longer than during the past century, but this has also caused an increase of the prevalence of many neurologi …
Autonomic dysfunction in Parkinson's disease: Implications for pathophysiology, diagnosis, and treatment.
Chen Z, Li G, Liu J. Chen Z, et al. Neurobiol Dis. 2020 Feb;134:104700. doi: 10.1016/j.nbd.2019.104700. Epub 2019 Dec 3. Neurobiol Dis. 2020. PMID: 31809788 Free article. Review.
Parkinson's disease (PD) is a neurodegenerative disease with a 200 year-long research history. ...
Parkinson's disease (PD) is a neurodegenerative disease with a 200 year-long research history. ...
27,113 results
You have reached the last available page of results. Please see the User Guide for more information.